The interaction between the immune and skeletal systems is evidenced by the bone loss observed in autoimmune diseases such as rheumatoid arthritis. In this paper we describe a new mechanism by which the immune cytokine IL-17A directly affects osteoclastogenesis.
Discovery Research, Schering-Plough Biopharma (formerly DNAX Research, Inc,), 901 South California Avenue, Palo Alto, CA 94304, USA. iannis.adamopoulos@spcorp.com